![赛琳生物制药(老挝)有限公司[官网]](/skin/img/logo.png){kind=logo}
Solid Preparation
Crizotinib
That developed by the American Pfizer inhibition of ALK ROS1 / Met more ATP competitive target protein kinase inhibitor, in ALK, Met and ROS1 kinase activity in patients with abnormal tumor confirmed significant clinical curative effect to human body, azole to help is the most rapid in cancer drug development history of one of the drugs.
Indications: for the patients with tumor
Specification: 250 mg * 60 grains
Unit: box
Retail price: $500
Note: that developed by the American Pfizer inhibition of ALK/ROS1 / Met more ATP competitive target protein kinase inhibitors
Indications: for the patients with tumor
Specification: 250 mg * 60 grains
Unit: box
Retail price: $500
Note: that developed by the American Pfizer inhibition of ALK/ROS1 / Met more ATP competitive target protein kinase inhibitors